258 related articles for article (PubMed ID: 28834763)
1. Overcoming resistance to cisplatin by inhibition of glutathione S-transferases (GSTs) with ethacraplatin micelles in vitro and in vivo.
Li S; Li C; Jin S; Liu J; Xue X; Eltahan AS; Sun J; Tan J; Dong J; Liang XJ
Biomaterials; 2017 Nov; 144():119-129. PubMed ID: 28834763
[TBL] [Abstract][Full Text] [Related]
2. Characterization of new potential anticancer drugs designed to overcome glutathione transferase mediated resistance.
Johansson K; Ito M; Schophuizen CM; Mathew Thengumtharayil S; Heuser VD; Zhang J; Shimoji M; Vahter M; Ang WH; Dyson PJ; Shibata A; Shuto S; Ito Y; Abe H; Morgenstern R
Mol Pharm; 2011 Oct; 8(5):1698-708. PubMed ID: 21851097
[TBL] [Abstract][Full Text] [Related]
3. Rational design of platinum(IV) compounds to overcome glutathione-S-transferase mediated drug resistance.
Ang WH; Khalaila I; Allardyce CS; Juillerat-Jeanneret L; Dyson PJ
J Am Chem Soc; 2005 Feb; 127(5):1382-3. PubMed ID: 15686364
[TBL] [Abstract][Full Text] [Related]
4. A cisplatin-based platinum(IV) prodrug containing a glutathione s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer.
Chen H; Wang X; Gou S
J Inorg Biochem; 2019 Apr; 193():133-142. PubMed ID: 30731264
[TBL] [Abstract][Full Text] [Related]
5. Development of an Efficient Dual-Action GST-Inhibiting Anticancer Platinum(IV) Prodrug.
Lee KGZ; Babak MV; Weiss A; Dyson PJ; Nowak-Sliwinska P; Montagner D; Ang WH
ChemMedChem; 2018 Jun; 13(12):1210-1217. PubMed ID: 29637702
[TBL] [Abstract][Full Text] [Related]
6. Multipronged Design of Light-Triggered Nanoparticles To Overcome Cisplatin Resistance for Efficient Ablation of Resistant Tumor.
Li Y; Deng Y; Tian X; Ke H; Guo M; Zhu A; Yang T; Guo Z; Ge Z; Yang X; Chen H
ACS Nano; 2015 Oct; 9(10):9626-37. PubMed ID: 26365698
[TBL] [Abstract][Full Text] [Related]
7. Multifunctional Pt(iv) complexes containing a glutathione S-transferase inhibitor lead to enhancing anticancer activity and preventing metastasis of osteosarcoma cells.
Chen H; Chen F; Wang X; Gou S
Metallomics; 2019 Feb; 11(2):317-326. PubMed ID: 30560252
[TBL] [Abstract][Full Text] [Related]
8. Intracellular glutathione-depleting polymeric micelles for cisplatin prodrug delivery to overcome cisplatin resistance of cancers.
Han Y; Yin W; Li J; Zhao H; Zha Z; Ke W; Wang Y; He C; Ge Z
J Control Release; 2018 Mar; 273():30-39. PubMed ID: 29371047
[TBL] [Abstract][Full Text] [Related]
9. Glutathione-S-transferases and Chemotherapy Resistance of Hodgkin's Lymphoma Cell Lines.
Bernig T; Ritz S; Brodt G; Volkmer I; Staege MS
Anticancer Res; 2016 Aug; 36(8):3905-15. PubMed ID: 27466493
[TBL] [Abstract][Full Text] [Related]
10. The role of glutathione-S-transferase in anti-cancer drug resistance.
Townsend DM; Tew KD
Oncogene; 2003 Oct; 22(47):7369-75. PubMed ID: 14576844
[TBL] [Abstract][Full Text] [Related]
11. Studies of glutathione transferase P1-1 bound to a platinum(IV)-based anticancer compound reveal the molecular basis of its activation.
Parker LJ; Italiano LC; Morton CJ; Hancock NC; Ascher DB; Aitken JB; Harris HH; Campomanes P; Rothlisberger U; De Luca A; Lo Bello M; Ang WH; Dyson PJ; Parker MW
Chemistry; 2011 Jul; 17(28):7806-16. PubMed ID: 21681839
[TBL] [Abstract][Full Text] [Related]
12. Short divalent ethacrynic amides as pro-inhibitors of glutathione
Xu B; Tong T; Wang X; Liu F; Zhang X; Hu X; Li X; Yang X; Liao F
J Enzyme Inhib Med Chem; 2022 Dec; 37(1):728-742. PubMed ID: 35176963
[TBL] [Abstract][Full Text] [Related]
13. A study of ethacrynic acid as a potential modifier of melphalan and cisplatin sensitivity in human lung cancer parental and drug-resistant cell lines.
Rhodes T; Twentyman PR
Br J Cancer; 1992 May; 65(5):684-90. PubMed ID: 1316774
[TBL] [Abstract][Full Text] [Related]
14. Pt(IV) prodrugs containing microtubule inhibitors displayed potent antitumor activity and ability to overcome cisplatin resistance.
Li L; Huang X; Huang R; Gou S; Wang Z; Wang H
Eur J Med Chem; 2018 Aug; 156():666-679. PubMed ID: 30031977
[TBL] [Abstract][Full Text] [Related]
15. An H₂O₂-responsive nanocarrier for dual-release of platinum anticancer drugs and O₂: controlled release and enhanced cytotoxicity against cisplatin resistant cancer cells.
Chen H; He W; Guo Z
Chem Commun (Camb); 2014 Sep; 50(68):9714-7. PubMed ID: 25017175
[TBL] [Abstract][Full Text] [Related]
16. Overcoming tumor resistance to cisplatin through micelle-mediated combination chemotherapy.
Zhou D; Cong Y; Qi Y; He S; Xiong H; Wu Y; Xie Z; Chen X; Jing X; Huang Y
Biomater Sci; 2015 Jan; 3(1):182-91. PubMed ID: 26214201
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of cisplatin sensitivity in cisplatin-resistant human bladder cancer cells by modulating glutathione concentrations and glutathione-related enzyme activities.
Byun SS; Kim SW; Choi H; Lee C; Lee E
BJU Int; 2005 May; 95(7):1086-90. PubMed ID: 15839938
[TBL] [Abstract][Full Text] [Related]
18. Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death.
Singh S
Cancer Chemother Pharmacol; 2015 Jan; 75(1):1-15. PubMed ID: 25143300
[TBL] [Abstract][Full Text] [Related]
19. The pleiotropic effects of ethacrynic acid.
Somberg JC; Molnar J
Am J Ther; 2009; 16(1):102-4. PubMed ID: 19142157
[TBL] [Abstract][Full Text] [Related]
20. In vitro reversal of glutathione-S-transferase-mediated resistance in canine osteosarcoma (COS31) cells.
Shoieb AM; Hahn KA; Van Laack RL; Barnhill MA
In Vivo; 1998; 12(5):455-62. PubMed ID: 9827351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
